{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:39:39Z","timestamp":1785494379958,"version":"3.56.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T00:00:00Z","timestamp":1705276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T00:00:00Z","timestamp":1705276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10557-024-07546-4","type":"journal-article","created":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T09:02:53Z","timestamp":1705309373000},"page":"553-562","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of Midodrine Utilization in Patients with Cancer and Heart Failure"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6394-2543","authenticated-orcid":false,"given":"Jorge A.","family":"Irizarry-Caro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhee","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chase","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Going","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Fossas-Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya M.","family":"Fatakdawala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cezar","family":"Iliescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Palaskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Deswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstratios","family":"Koutroumpakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,15]]},"reference":[{"issue":"4","key":"7546_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4251\/wjgo.v7.i4.17","volume":"7","author":"T Aoyagi","year":"2015","unstructured":"Aoyagi T, Terracina KP, Raza A, Matsubara H, Takabe K. Cancer cachexia, mechanism and treatment. World J Gastrointest Oncol. 2015;7(4):17\u201329. https:\/\/doi.org\/10.4251\/wjgo.v7.i4.17.","journal-title":"World J Gastrointest Oncol"},{"issue":"25","key":"7546_CR2","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1161\/01.CIR.0000133187.74800.B9","volume":"109","author":"ET Yeh","year":"2004","unstructured":"Yeh ET, Tong AT, Lenihan DJ, et al. Cardiovascular complications of cancer therapy: Diagnosis, pathogenesis, and management. Circulation. 2004;109(25):3122\u201331. https:\/\/doi.org\/10.1161\/01.CIR.0000133187.74800.B9.","journal-title":"Circulation"},{"issue":"10","key":"7546_CR3","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1093\/ndt\/gfh420","volume":"19","author":"S Prakash","year":"2004","unstructured":"Prakash S, Garg AX, Heidenheim AP, House AA. Midodrine appears to be safe and effective for dialysis-induced hypotension: A systematic review. Nephrol Dial Transplant. 2004;19(10):2553\u20138. https:\/\/doi.org\/10.1093\/ndt\/gfh420.","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"7546_CR4","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1177\/0885066619843279","volume":"35","author":"DA Hammond","year":"2020","unstructured":"Hammond DA, Smith MN, Peksa GD, Trivedi AP, Balk RA, Menich BE. Midodrine as an adjuvant to intravenous vasopressor agents in adults with resolving shock: Systematic review and meta-analysis. J Intensive Care Med. 2020;35(11):1209\u201315. https:\/\/doi.org\/10.1177\/0885066619843279.","journal-title":"J Intensive Care Med"},{"issue":"3","key":"7546_CR5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/MEG.0000000000001277","volume":"31","author":"A Yosry","year":"2019","unstructured":"Yosry A, Soliman ZA, Eletreby R, Hamza I, Ismail A, Elkady MA. Oral midodrine is comparable to albumin infusion in cirrhotic patients with refractory ascites undergoing large-volume paracentesis: Results of a pilot study. Eur J Gastroenterol Hepatol. 2019;31(3):345\u201351. https:\/\/doi.org\/10.1097\/MEG.0000000000001277.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"7546_CR6","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/hep.31884","volume":"74","author":"SW Biggins","year":"2021","unstructured":"Biggins SW, Angeli P, Garcia-Tsao G, et al. Diagnosis, evaluation, and Management of Ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;74(2):1014\u201348. https:\/\/doi.org\/10.1002\/hep.31884.","journal-title":"Hepatology"},{"issue":"5","key":"7546_CR7","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10741-016-9541-z","volume":"21","author":"O Gorelik","year":"2016","unstructured":"Gorelik O, Feldman L, Cohen N. Heart failure and orthostatic hypotension. Heart Fail Rev. 2016;21(5):529\u201338. https:\/\/doi.org\/10.1007\/s10741-016-9541-z.","journal-title":"Heart Fail Rev"},{"issue":"8","key":"7546_CR8","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/ejhf.1835","volume":"22","author":"J Cautela","year":"2020","unstructured":"Cautela J, Tartiere JM, Cohen-Solal A, et al. Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients. Eur J Heart Fail. 2020;22(8):1357\u201365. https:\/\/doi.org\/10.1002\/ejhf.1835.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"7546_CR9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1751-7133.2008.00042.x","volume":"15","author":"RM Zakir","year":"2009","unstructured":"Zakir RM, Folefack A, Saric M, Berkowitz RL. The use of midodrine in patients with advanced heart failure. Congest Heart Fail. 2009;15(3):108\u201311. https:\/\/doi.org\/10.1111\/j.1751-7133.2008.00042.x.","journal-title":"Congest Heart Fail"},{"key":"7546_CR10","doi-asserted-by":"publisher","unstructured":"Vijayaraghavan K, Little D, Mercer T, et al. Midodrine as a bridge to enable use of life enhancing therapies in chronic heart failure. J Cardiac Fail. 2020;26(10):S59. https:\/\/doi.org\/10.1016\/j.cardfail.2020.09.175.","DOI":"10.1016\/j.cardfail.2020.09.175"},{"key":"7546_CR11","doi-asserted-by":"publisher","unstructured":"Scoma C, Dae-Hyun L, Cohen A, Fernandez J. Prevalence of midodrine use in patients admitted with systolic congestive heart. J Am Coll Cardiol. 2021;77(18):678. https:\/\/doi.org\/10.1016\/S0735-1097(21)02037-4.","DOI":"10.1016\/S0735-1097(21)02037-4"},{"key":"7546_CR12","doi-asserted-by":"publisher","unstructured":"Shiu P, Grewal GS, Kozik TM. Midodrine to optimize heart failure therapy in patients with concurrent hypotension. SAGE Open Med Case Rep. 2022;10:2050313X221100400. https:\/\/doi.org\/10.1177\/2050313X221100400.","DOI":"10.1177\/2050313X221100400"},{"issue":"1","key":"7546_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/107424840501000109","volume":"10","author":"S Sharma","year":"2005","unstructured":"Sharma S, Bhambi B. Successful treatment of hypotension associated with stunned myocardium with oral midodrine therapy. J Cardiovasc Pharmacol Ther. 2005;10(1):77\u20139. https:\/\/doi.org\/10.1177\/107424840501000109.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"6","key":"7546_CR14","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/MAJ.0b013e3181b7efa7","volume":"338","author":"SM Bergman","year":"2009","unstructured":"Bergman SM. Hemodialysis in hypotensive heart failure using midodrine. Am J Med Sci. 2009;338(6):470\u20133. https:\/\/doi.org\/10.1097\/MAJ.0b013e3181b7efa7.","journal-title":"Am J Med Sci"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-024-07546-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-024-07546-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-024-07546-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T09:21:51Z","timestamp":1748337711000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-024-07546-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,15]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["7546"],"URL":"https:\/\/doi.org\/10.1007\/s10557-024-07546-4","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,15]]},"assertion":[{"value":"3 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"EK is supported in part by NIH\/NCI 1RO1HL157273 and by CPRIT RP200381. AD is supported in part by the Ting Tsung and Wei Fong Chao Distinguished Chair. NP is a Cancer Prevention Research Institute of Texas (CPRIT) Scholar and Andrew Sabin Family Foundation Fellow. NP is supported by CPRIT RP200670 and by NIH\/NCI 1P01CA261669-01. Otherwise, the authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The study protocol was approved by the institutional review board at the University of Texas MD Anderson Cancer Center.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"A waiver of patient consent was obtained given the retrospective nature of the study. This manuscript does not include patients\u2019 personal information or patients\u2019 photographs.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All co-authors have approved the publication of this manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}}]}}